Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype

M. Shahmanesh*, H. Jaleel, Y. DeSilva, J. D.C. Ross, M. Caslake, R. Cramb

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    6 Citations (SciVal)

    Fingerprint

    Dive into the research topics of 'Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology